{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:30:04Z","timestamp":1787679004822,"version":"build-2784847793"},"reference-count":95,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.clindermatol.2013.06.011","type":"journal-article","created":{"date-parts":[[2013,9,27]],"date-time":"2013-09-27T14:06:12Z","timestamp":1380290772000},"page":"544-554","source":"Crossref","is-referenced-by-count":99,"title":["Therapies for the treatment of onychomycosis"],"prefix":"10.1016","volume":"31","author":[{"given":"Aditya K.","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryse","family":"Paquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona C.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2013.06.011_bb0005","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1517\/14656566.2012.681779","article-title":"New therapeutic options for onychomycosis","volume":"13","author":"Gupta","year":"2012","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0010","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1046\/j.1365-2133.2003.05418.x","article-title":"In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity","volume":"149","author":"Gupta","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11046-007-9027-6","article-title":"Identification and in vitro antifungal susceptibility testing of 200 clinical isolates of Candida spp. responsible for fingernail infections","volume":"164","author":"Figueiredo","year":"2007","journal-title":"Mycopathologia"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2133.149.s65.4.x","article-title":"Epidemiology, clinical presentation and diagnosis of onychomycosis","volume":"149","author":"Faergemann","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0025","doi-asserted-by":"crossref","first-page":"551","DOI":"10.7547\/87507315-87-12-551","article-title":"Traditional approaches to treatment of onychomycosis","volume":"87","author":"Markinson","year":"1997","journal-title":"J Am Podiatr Med Assoc"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0030","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1473-2130.2004.00095.x","article-title":"Nail abrasion","volume":"2","author":"Di Chiacchio","year":"2003","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0035","doi-asserted-by":"crossref","first-page":"299","DOI":"10.4103\/0378-6323.95444","article-title":"Nail avulsion: indications and methods (surgical nail avulsion)","volume":"78","author":"Pandhi","year":"2012","journal-title":"Ind J Dermatol Venereol Leprol"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0040","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1080\/09546630701243418","article-title":"Review of antifungal therapy and the severity index for assessing onychomycosis: part I","volume":"19","author":"Baran","year":"2008","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0045","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/09546630212345672","article-title":"Chemical avulsion with urea nail lacquer","volume":"13","author":"Baran","year":"2002","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0050","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/09546630510025950","article-title":"Combination of fluconazole and urea in a nail lacquer for treating onychomycosis","volume":"16","author":"Baran","year":"2005","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0055","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000249920","article-title":"Treatment of onychomycosis by partial nail avulsion and topical miconazole","volume":"165","author":"Rollman","year":"1982","journal-title":"Dermatologica"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0060","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0190-9622(00)90129-4","article-title":"Onychomycosis caused by nondermatophytic molds: clinical features and response to treatment of 59 cases","volume":"42","author":"Tosti","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0065","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1365-2133.2007.08014.x","article-title":"Combination of surgical avulsion and topical therapy for single nail onychomycosis: a randomized controlled trial","volume":"157","author":"Grover","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0070","first-page":"127","article-title":"Clinical characteristics and treatment outcomes of patients undergoing nail avulsion surgery for dystrophic nails","volume":"17","author":"Lai","year":"2011","journal-title":"Hong Kong Med J"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0075","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1439-0507.2004.01090.x","article-title":"New insights into the effect of amorolfine nail lacquer","volume":"48","author":"Flagothier","year":"2005","journal-title":"Mycoses"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0080","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/j.1610-0387.2010.07499.x","article-title":"Today\u2019s treatments options for onychomycosis","volume":"8","author":"Iorizzo","year":"2010","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0085","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1468-3083.2005.01284.x","article-title":"Feuilhade de Chauvin M, et al. Treatment options\u2013development of consensus guidelines","volume":"19","author":"Lecha","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0090","doi-asserted-by":"crossref","first-page":"659","DOI":"10.4103\/0378-6323.86475","article-title":"Onychomycosis: diagnosis and management","volume":"77","author":"Singal","year":"2011","journal-title":"Ind J Dermatol Venereol Leprol"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0095","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0733-8635(03)00025-1","article-title":"The use of topical therapies to treat onychomycosis","volume":"21","author":"Gupta","year":"2003","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0100","author":"Medicines and Healthcare Products Regulatory Agency"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0105","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1525-1470.2006.00272.x","article-title":"Rapid response of distal subungual onychomycosis to 5% amorolfine nail lacquer in a 20-month-old healthy infant","volume":"23","author":"Hsu","year":"2006","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0110","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1046\/j.1468-3083.2001.00182.x","article-title":"Superficial white onychomycosis in a 3-year-old human immunodeficiency virus-infected child","volume":"15","author":"Pe\u00f1a-Penabad","year":"2001","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0115","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.clinthera.2006.12.011","article-title":"The relation between intermittent dosing and adherence: preliminary insights","volume":"28","author":"Kruk","year":"2006","journal-title":"Clin Therapeutics"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0120","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000247612","article-title":"Topical treatment of onychomycosis with amorolfine 5% nail lacquer: comparative efficacy and tolerability of once and twice weekly use","volume":"184","author":"Reinel","year":"1992","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0125","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2230.1992.tb00274.x","article-title":"Determination of the subungual antifungal activity of amorolfine after 1 month's treatment in patients with onychomycosis: comparison of two nail lacquer formulations","volume":"17","author":"Mensing","year":"1992","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0130","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2230.1992.tb00277.x","article-title":"Comparative efficacy and safety of amorolfine nail lacquer 2% versus 5% once weekly","volume":"17","author":"Lauharanta","year":"1992","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0135","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1365-2230.1992.tb00278.x","article-title":"Comparative efficacy and safety of amorolfine nail lacquer 5% in onychomycosis, once-weekly versus twice-weekly","volume":"17","author":"Reinel","year":"1992","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0140","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1067\/mjd.2000.109072","article-title":"Dermatopharmacology of ciclopirox nail lacquer topical solution 8% in the treatment of onychomycosis","volume":"43","author":"Bohn","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0145","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.2165\/11538110-000000000-00000","article-title":"Ciclopirox: recent nonclinical and clinical data relevant to its use as a topical antimycotic agent","volume":"70","author":"Subissi","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0150","author":"Dermik Laboratories"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0155","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1468-3083.2009.03164.x","article-title":"An innovative water-soluble biopolymer improves efficacy of ciclopirox nail lacquer in the management of onychomycosis","volume":"23","author":"Baran","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0160","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1365-2133.2005.07110.x","article-title":"Congenital candidal onychomycoses: effective cure with ciclopirox olamine 8% nail lacquer","volume":"154","author":"Sardana","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0165","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1525-1470.2009.01034.x","article-title":"Onychomycosis in a very young child","volume":"26","author":"Zac","year":"2009","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0170","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1365-4632.2008.03969.x","article-title":"Trichophyton rubrum onychomycosis in a 10-week-old infant","volume":"49","author":"Sachdeva","year":"2010","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0175","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0190-9622(97)70321-9","article-title":"Childhood white superficial onychomycosis caused by Trichophyton rubrum: report of seven cases and review of the literature","volume":"36","author":"Ploysangam","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0180","author":"Valeant"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0185","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1365-2710.2009.01107.x","article-title":"Toenail onychomycosis: an important global disease burden","volume":"35","author":"Thomas","year":"2010","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0190","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/S0190-9622(09)80305-8","article-title":"Mechanisms of action of systemic antifungal agents","volume":"28","author":"Elewski","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0195","doi-asserted-by":"crossref","first-page":"e679","DOI":"10.1111\/j.1439-0507.2011.02038.x","article-title":"Recent updates in oral terbinafine: its use in onychomycosis and tinea capitis in the US","volume":"54","author":"Van Duyn Graham","year":"2011","journal-title":"Mycoses"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0200","author":"Novartis Pharmaceuticals Corporation"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0205","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.0736-8046.2004.21117.x","article-title":"Onychomycosis in children: a brief overview with treatment strategies","volume":"21","author":"Gupta","year":"2004","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0210","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1365-2133.1995.tb00711.x","article-title":"Overview of the use of terbinafine (Lamisil) in children","volume":"132","author":"Jones","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0215","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1468-3083.2007.02498.x","article-title":"Onychomycosis: a new emerging infectious disease in childhood population and adolescents. Report on treatment experience with terbinafine and itraconazole in 36 patients","volume":"22","author":"Ginter-Hanselmayer","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0220","author":"Novartis Pharmaceuticals Corporation"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0225","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2165\/00128071-200304010-00005","article-title":"Terbinafine: a review of its use in onychomycosis in adults","volume":"4","author":"Darkes","year":"2003","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0230","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3109\/09546634.2011.579082","article-title":"A meta-analysis comparing long-term recurrences of toenail onychomycosis after successful treatment with terbinafine versus itraconazole","volume":"23","author":"Yin","year":"2012","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0235","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1757-1146-4-26","article-title":"Safety and efficacy of tinea pedis and onychomycosis treatment in people with diabetes: a systematic review","volume":"4","author":"Matricciani","year":"2011","journal-title":"J Foot Ankle Res"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0240","author":"Novartis Pharmaceuticals Corporation"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0250","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0733-8635(05)70460-5","article-title":"Oral antifungal drug interactions","volume":"15","author":"Katz","year":"1997","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0255","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1046\/j.1365-4362.1999.00014.x","article-title":"Safety review of the oral antifungal agents used to treat superficial mycoses","volume":"38","author":"Gupta","year":"1999","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0260","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1610-0387.2008.06751.x","article-title":"The significance of itraconazole for treatment of fungal infections of skin, nails and mucous membranes","volume":"7","author":"Korting","year":"2009","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0265","author":"Janssen"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0270","author":"Ortho-McNeil-Janssen Pharmaceuticals"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0275","first-page":"101","article-title":"Mycoses in children: systemic treatment","volume":"7","author":"Ginter","year":"1998","journal-title":"Acta Dermatovenerol Ala Panonica Adriat"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0280","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1080\/000155502762064764","article-title":"Onychomycosis in children: treatment results of forty-seven patients","volume":"82","author":"Heikkil\u00e4","year":"2002","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0290","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0190-9622(97)70275-5","article-title":"Itraconazole therapy is effective for pedal onychomycosis caused by some nondermatophyte molds and in mixed infection with dermatophytes and molds: a multicenter study with 36 patients","volume":"36","author":"De Doncker","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0295","author":"Janssen"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0300","doi-asserted-by":"crossref","first-page":"198","DOI":"10.4103\/0019-5154.62746","article-title":"A meta-analysis comparing efficacy of continuous terbinafine with intermittent itraconazole for toenail onychomycosis","volume":"55","author":"Trivedi","year":"2010","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0305","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/09546634.2012.703308","article-title":"Evidence-based optimal fluconazole dosing regimen for onychomycosis treatment","volume":"24","author":"Gupta","year":"2013","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0310","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0733-8635(03)00036-6","article-title":"Treatment of nondermatophyte mold and Candida onychomycosis","volume":"21","author":"Tosti","year":"2003","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0315","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1525-1470.1996.tb00732.x","article-title":"Successful treatment of onychomycosis with fluconazole in two patients with hyperimmunoglobulin E syndrome","volume":"13","author":"Aihara","year":"1996","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0320","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0190-9622(96)90327-8","article-title":"Intermittent fluconazole dosing in patients with onychomycosis: results of a pilot study","volume":"35","author":"Assaf","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0325","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0190-9622(97)80215-0","article-title":"Onychomycosis in children: prevalence and treatment strategies","volume":"36","author":"Gupta","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0330","first-page":"390","article-title":"Recurrent proximal white subungual onychomycosis associated with a defect of the polymorphonuclear chemotaxis","volume":"9","author":"Gianni","year":"1999","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0335","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1439-0507.2005.01161.x","article-title":"Onychomycosis in children: a survey of 46 cases","volume":"48","author":"Romano","year":"2005","journal-title":"Mycoses"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0340","author":"Pfizer"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0345","author":"Pfizer"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0350","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1345\/aph.1M165","article-title":"Efficacy of fluconazole for the treatment of onychomycosis","volume":"43","author":"Brown","year":"2009","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0355","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1751-1097.2009.00672.x","article-title":"Direct antifungal effect of femtosecond laser on Trichophyton rubrum onychomycosis","volume":"86","author":"Manevitch","year":"2010","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0360","author":"Pfizer"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0365","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1126\/science.6836297","article-title":"Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation","volume":"220","author":"Anderson","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0370","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10103-007-0492-4","article-title":"The effects of laser irradiation on Trichophyton rubrum growth","volume":"23","author":"Vural","year":"2008","journal-title":"Lasers Med Sci"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0385","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3109\/14764172.2011.552616","article-title":"Laser treatment of onychomycosis using a novel 0.65-millisecond pulsed Nd:YAG 1064-nm laser","volume":"13","author":"Hochman","year":"2011","journal-title":"J Cosmet Laser Ther"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0395","author":"Waibel"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0405","first-page":"1","article-title":"Laser treatment for toenail fungus","volume":"7161","author":"Harris","year":"2009","journal-title":"Proc of SPIE"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0415","author":"Weiss"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0420","first-page":"496","article-title":"Treating onychomycoses of the toenail: clinical efficacy of the sub-millisecond 1,064 nm Nd: YAG laser using a 5 mm spot diameter","volume":"11","author":"Kimura","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0430","unstructured":"CoolTouch Inc. CoolTouch CT3Plus Laser Specifications. Available at http:\/\/www.cooltouch.com\/CT3Plus_specifications.aspx. Accessed June 8, 2012."},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0435","author":"Lutronic Corporation"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0440","author":"Alma Lasers"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0445","author":"Light Age Inc"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0450","doi-asserted-by":"crossref","first-page":"166","DOI":"10.7547\/1000166","article-title":"Treatment of mild, moderate, and severe onychomycosis using 870- and 930-nm light exposure","volume":"100","author":"Landsman","year":"2010","journal-title":"J Am Podiatr Med Assoc"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0455","doi-asserted-by":"crossref","first-page":"169","DOI":"10.7547\/1020169","article-title":"Treatment of mild, moderate, and severe onychomycosis using 870- and 930-nm light exposure: some follow-up observations at 270 days","volume":"102","author":"Landsman","year":"2012","journal-title":"J Am Podiatr Med Assoc"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0460","author":"ConBio"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0465","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1365-2133.1997.tb03662.x","article-title":"Evaluation of 6 weeks treatment of terbinafine in tinea unguium in a double-blind trial comparing 6 and 12 weeks therapy. The Lagos V Study Group","volume":"136","author":"Tausch","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0470","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1046\/j.1365-2133.2003.05728.x","article-title":"Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis","volume":"150","author":"Gupta","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0475","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s102270000019","article-title":"Itraconazole and terbinafine treatment of some nondermatophyte molds causing onychomycosis of the toes and a review of the literature","volume":"5","author":"Gupta","year":"2001","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0480","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1046\/j.1365-4362.2001.01204.x","article-title":"Efficacy and safety of terbinafine for nondermatophyte and mixed nondermatophyte and dermatophyte toenail onychomycosis","volume":"40","author":"Lebwohl","year":"2001","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0485","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000079593","article-title":"Clinical and histological aspects of toenail onychomycosis caused by Aspergillus spp.: 34 cases treated with weekly intermittent terbinafine","volume":"209","author":"Gianni","year":"2004","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0490","doi-asserted-by":"crossref","first-page":"262","DOI":"10.4103\/0378-6323.16619","article-title":"An open randomized comparative study of oral itraconazole pulse and terbinafine pulse in the treatment of onychomycosis","volume":"71","author":"Mishra","year":"2005","journal-title":"Ind J Dermatol Venereol Leprol"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0495","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000051643","article-title":"Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes","volume":"202","author":"Gupta","year":"2001","journal-title":"Dermatology (Basel)"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0500","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0190-9622(96)90120-6","article-title":"Treatment of Candida nail infection with terbinafine","volume":"35","author":"Segal","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0505","first-page":"258","article-title":"Open label trial of the efficacy and tolerability of Lamisil (terbinafine) 500 mg once daily in the treatment of onychomycosis due to Candida","volume":"46","author":"Zaidi","year":"1996","journal-title":"J Park Med Assoc"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0510","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1046\/j.1468-3083.2001.00206.x","article-title":"Itraconazole pulse therapy for the treatment of Candida onychomycosis","volume":"15","author":"Gupta","year":"2001","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2013.06.011_bb0515","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1365-4632.2004.02117.x","article-title":"A pilot evaluation of pulse itraconazole vs. terbinafine for treatment of Candida toenail onychomycosis","volume":"44","author":"Warshaw","year":"2005","journal-title":"Int J Dermatol"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X13001405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X13001405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T12:59:07Z","timestamp":1539349147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X13001405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":95,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0738081X13001405"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2013.06.011","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}